| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |